Prospective evaluation of the Kaiser Permanente prostate cancer risk calculator in biopsy-naïve men with mild PSA elevations

被引:0
|
作者
Presti, Joseph
Horton, Brandon
Alexeeff, Stacey
Prausnitz, Stephanie
Avins, Andrew
机构
[1] Kaiser Permanente, San Francisco, CA USA
[2] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
关键词
3282-206-3782-4974; 2;
D O I
10.1200/JCO.2024.42.4_suppl.290
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:290 / 290
页数:1
相关论文
共 50 条
  • [1] Prospective Evaluation of the Kaiser Permanente Prostate Cancer Risk Calculator in Biopsy-Naïve Men With Mild PSA Elevations
    Presti Jr, Joseph
    Horton, Brandon
    Alexeeff, Stacey
    Prausnitz, Stephanie
    Avins, Andrew L.
    UROLOGY PRACTICE, 2024, 11 (05)
  • [2] Prospective development of a prostate cancer risk calculator in a racially diverse population: The Kaiser Permanente Prostate Cancer Risk Calculator
    Presti, Joseph
    Alexeeff, Stacey
    Horton, Brandon
    Prausnitz, Stephanie
    Avins, Andrew L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (11) : 847.e1 - 847.e8
  • [3] Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral population
    Presti, Joseph C.
    Alexeeff, Stacey
    Horton, Brandon
    Prausnitz, Stephanie
    Avins, Andrew L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (11) : 783.e11 - 783.e19
  • [4] Performance of prostate health index and PSA density in a diverse biopsy-naïve cohort with mpMRI for detecting significant prostate cancer
    Carbunaru, Samuel
    Stinson, James
    Babajide, Rilwan
    Hollowell, Courtney M. P.
    Yang, Ximing
    Sekosan, Marin
    Ferrer, Karen
    Kajdacsy-Balla, Andre
    Abelleira, Josephine
    Ruden, Maria
    King-Lee, Patrice
    Dalton, Daniel P.
    Casalino, David D.
    Kittles, Rick A.
    Gann, Peter H.
    Schaeffer, Edward M.
    Murphy, Adam B.
    BJUI COMPASS, 2021, 2 (06): : 370 - 376
  • [5] Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men
    Rianne J. Hendriks
    Marloes M. G. van der Leest
    Bas Israël
    Gerjon Hannink
    Anglita YantiSetiasti
    Erik B. Cornel
    Christina A. Hulsbergen-van de Kaa
    O. Sjoerd Klaver
    J. P. Michiel Sedelaar
    Wim Van Criekinge
    Hans de Jong
    Peter F. A. Mulders
    E. David Crawford
    Jeroen Veltman
    Jack A. Schalken
    Jelle O. Barentsz
    Inge M. van Oort
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 1110 - 1119
  • [6] A nomogram based on biparametric magnetic resonance imaging for detection of clinically significant prostate cancer in biopsy-naïve patients
    Beibei Hu
    Huili Zhang
    Yueyue Zhang
    Yongming Jin
    Cancer Imaging, 23
  • [7] Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients
    Hesham Abdel-Azim El-Helaly
    Asem Abdel-Aziz Mahmoud
    Ahmed Mohamed Magdy
    Abdelwahab Hasehem
    Hamdy Mohamed Ibrahim
    Khaled Moheyelden Mohamed
    Mohamed Hamdy Ismail
    Journal of the Egyptian National Cancer Institute, 35
  • [8] A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies
    Lars Boesen
    Frederik B. Thomsen
    Nis Nørgaard
    Vibeke Løgager
    Ingegerd Balslev
    Rasmus Bisbjerg
    Henrik S. Thomsen
    Henrik Jakobsen
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 609 - 616
  • [9] The role of transperineal template prostate biopsies in prostate cancer diagnosis in biopsy naïve men with PSA less than 20 ng ml−1
    S Nafie
    J K Mellon
    J P Dormer
    M A Khan
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 170 - 173
  • [10] Cognitive Targeted Prostate Biopsy Alone for Diagnosing Clinically Significant Prostate Cancer in Selected Biopsy-Naïve Patients: Results from a Retrospective Pilot Study
    Olivetta, Michelangelo
    Manfredi, Celeste
    Spirito, Lorenzo
    Quattrone, Carmelo
    Bottone, Francesco
    Stizzo, Marco
    Amicuzi, Ugo
    Lecce, Arturo
    Rubinacci, Andrea
    Romano, Lorenzo
    Della Rosa, Giampiero
    Papi, Salvatore
    Tammaro, Simone
    Coppola, Paola
    Arcaniolo, Davide
    Fusco, Ferdinando
    De Sio, Marco
    DIAGNOSTICS, 2024, 14 (15)